{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:13:38Z","timestamp":1783606418692,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K14757"],"award-info":[{"award-number":["23K14757"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jns.2026.125981","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:17:27Z","timestamp":1778080647000},"page":"125981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Longitudinal changes in brain volume, cognitive function, and seizure outcomes in cryptogenic new-onset refractory status epilepticus"],"prefix":"10.1016","volume":"488","author":[{"given":"Takafumi","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Neshige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Yorichika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keito","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riho","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Sakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Tagane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Tachiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Obayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jns.2026.125981_bb0005","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: Etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125981_bb0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2018.09.018","article-title":"New onset refractory status epilepticus (NORSE)","volume":"68","author":"Sculier","year":"2019","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.jns.2026.125981_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.47102\/annals-acadmedsg.V34N7p417","article-title":"The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity","volume":"34","author":"Wilder-Smith","year":"2005","journal-title":"Ann. Acad. Med. Singap."},{"issue":"12","key":"10.1016\/j.jns.2026.125981_bb0020","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2169\/internalmedicine.0465-22","article-title":"Reversible brain atrophy in cryptogenic new-onset refractory status epilepticus","volume":"62","author":"Watanabe","year":"2023","journal-title":"Intern. Med."},{"issue":"6","key":"10.1016\/j.jns.2026.125981_bb0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000396","article-title":"Cryptogenic NORSE: its distinctive clinical features and response to immunotherapy","volume":"4","author":"Iizuka","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.jns.2026.125981_bb0030","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2026.125981_bb0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.24806","article-title":"Febrile infection-related epilepsy syndrome treated with anakinra","volume":"80","author":"Kenney-Jung","year":"2016","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2026.125981_bb0040","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1111\/epi.17397","article-title":"International consensus recommendations for management of new onset refractory status epilepticus (NORSE) incl. Febrile infection-related epilepsy syndrome (FIRES): statements and supporting evidence","volume":"63","author":"Wickstrom","year":"2022","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.jns.2026.125981_bb0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.nrl.2022.03.005","article-title":"Functional outcomes of patients with NORSE and FIRES treated with immunotherapy: a systematic review","volume":"39","author":"Cabezudo-Garc\u00eda","year":"2024","journal-title":"Neurologia"},{"issue":"1","key":"10.1016\/j.jns.2026.125981_bb0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/epi4.13055","article-title":"Early initiation of intravenous cyclophosphamide and one-year outcome in super-refractory cryptogenic-new onset refractory status epilepticus","volume":"10","author":"Yorichika","year":"2025","journal-title":"Epilepsia Open"},{"issue":"10","key":"10.1016\/j.jns.2026.125981_bb0055","article-title":"Quality of life over time after new onset refractory status epilepticus","volume":"13","author":"Gruen","year":"2025","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.jns.2026.125981_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.32478","article-title":"Outcomes of critically ill adult patients with acute encephalitis","volume":"8","author":"Sonneville","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"Pt 10","key":"10.1016\/j.jns.2026.125981_bb0065","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jns.2026.125981_bb0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clineuro.2015.09.010","article-title":"Status epilepticus severity score (STESS): a useful tool to predict outcome of status epilepticus","volume":"139","author":"Goyal","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2026.125981_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1212\/WNL.94.15_supplement.188","article-title":"Clinical features, immunotherapy, and outcome in patients with cryptogenic NORSE","volume":"94","author":"Iizuka","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2026.125981_bb0080","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230024","article-title":"TotalSegmentator: robust segmentation of 104 anatomic structures in CT images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol. Artif. Intell."},{"key":"10.1016\/j.jns.2026.125981_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"A threshold selection method from gray-level histograms","author":"Otsu","year":"1979","journal-title":"IEEE Trans. Syst. Man Cybern."},{"issue":"1","key":"10.1016\/j.jns.2026.125981_bb0090","first-page":"11","article-title":"Hippocampal volume in normal aging and traumatic brain injury","volume":"18","author":"Bigler","year":"1997","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2026.125981_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2019.12.002","article-title":"New-onset refractory status epilepticus: a retrospective cohort study","volume":"74","author":"Gugger","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.jns.2026.125981_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.resuscitation.2019.07.006","article-title":"Incorporating baseline functional status to improve validity of neurological outcome assessments following cardiac arrest","volume":"142","author":"Eng","year":"2019","journal-title":"Resuscitation"},{"issue":"120100","key":"10.1016\/j.jns.2026.125981_bb0105","article-title":"A longitudinal seizure outcome following the COVID-19 pandemic in 2020 and 2021: transient exacerbation or sustainable mitigation","volume":"434","author":"Neshige","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.jns.2026.125981_bb0110","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/epi.17950","article-title":"Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE)","volume":"65","author":"Costello","year":"2024","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.jns.2026.125981_bb0115","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s10072-025-08082-1","article-title":"Clinical outcomes of cryptogenic new onset refractory status epilepticus (NORSE) in a tertiary hospital in Singapore: a case series","volume":"46","author":"Goh","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125981_bb0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.clinimag.2021.05.028","article-title":"Anti-NMDA receptor encephalitis and brain atrophy in children and adults: a quantitative study","volume":"78","author":"Bassal","year":"2021","journal-title":"Clin. Imaging"},{"issue":"110081","key":"10.1016\/j.jns.2026.125981_bb0125","article-title":"Brain damage caused by status epilepticus: a prospective MRI study","volume":"161","author":"Bosque Varela","year":"2024","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.jns.2026.125981_bb0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/arclin\/acz069","article-title":"Neuropsychological performance 1 year after status epilepticus in adults","volume":"36","author":"Gramstad","year":"2021","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.jns.2026.125981_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1095061","article-title":"Seizure burden and neuropsychological outcomes of new-onset refractory status epilepticus: systematic review","volume":"14","author":"Taraschenko","year":"2023","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2026.125981_bb0140","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1586\/14737175.2015.1079130","article-title":"Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application","volume":"15","author":"Vezzani","year":"2015","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jns.2026.125981_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1251914","article-title":"Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay","volume":"11","author":"Foiadelli","year":"2023","journal-title":"Front. Pediatr."},{"issue":"15","key":"10.1016\/j.jns.2026.125981_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157502","article-title":"Pathophysiology of status epilepticus revisited","volume":"26","author":"Alshehri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2026.125981_bb0155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2174\/1570159X21666221117152249","article-title":"Inflammation as treatment target for status epilepticus","volume":"21","author":"Rejdak","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"120693","key":"10.1016\/j.jns.2026.125981_bb0160","first-page":"29","article-title":"Cyclophosphamide for severe acute forms of central nervous system inflammatory disorders","volume":"451","author":"Osen","year":"2023","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2026.125981_bb0165","article-title":"Early recovery from cryptogenic NORSE following repeated C-NORSE score assessment and cyclophosphamide treatment: a case report","volume":"23","author":"Okochi","year":"2025","journal-title":"Intern. Med."},{"issue":"577789","key":"10.1016\/j.jns.2026.125981_bb0170","article-title":"Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment","volume":"363","author":"Wadayama","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.jns.2026.125981_bb0175","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1097\/MS9.0000000000000625","article-title":"Evidence-based guideline on management of status epilepticus in adult intensive care unit in resource-limited settings: a review article","volume":"85","author":"Besha","year":"2023","journal-title":"Ann. Med. Surg."},{"issue":"1","key":"10.1016\/j.jns.2026.125981_bb0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","article-title":"Predictors of outcome in refractory status epilepticus","volume":"70","author":"Hocker","year":"2013","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.jns.2026.125981_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11091182","article-title":"Risk of developing epilepsy after autoimmune encephalitis","volume":"11","author":"Gifreu","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.jns.2026.125981_bb0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2011.02.040","article-title":"Inflammation and prevention of epileptogenesis","volume":"497","author":"Ravizza","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.jns.2026.125981_bb0195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","article-title":"The role of inflammation in the development of epilepsy","volume":"15","author":"Rana","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"Suppl Suppl 2","key":"10.1016\/j.jns.2026.125981_bb0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/epi.14515","article-title":"Long-term outcomes of status epilepticus: a critical assessment","volume":"2","author":"Sculier","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.jns.2026.125981_bb0205","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200403","article-title":"Identification of distinct biological groups of patients with cryptogenic NORSE via inflammatory profiling","volume":"12","author":"Guillemaud","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.jns.2026.125981_bb0210","article-title":"Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: the DAME score","volume":"30","author":"Lattanzi","year":"2025","journal-title":"Epilepsia"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26002637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26002637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:19:24Z","timestamp":1783603164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26002637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S0022510X26002637"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125981","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal changes in brain volume, cognitive function, and seizure outcomes in cryptogenic new-onset refractory status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125981"}}